Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] - N0000193857

Name: Table of NDC products with orthopoxvirus vp37 envelope wrapping protein inhibitor
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000193857
Pharmacologic Name	Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor
Pharmacologic Uses	inhibitor of the orthopoxvirus VP37 envelope wrapping protein
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor

The table contains 2 products whose active ingredient are classified under the same pharmacologic class Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	50072-010	Tpoxx	Non-Proprietary Name: Tecovirimat Monohydrate	Injection, Solution, Concentrate	Intravenous	Siga Technologies, Inc.	ACTIVE
	50072-200	Tpoxx	Non-Proprietary Name: Tecovirimat Monohydrate	Capsule	Oral	Siga Technologies, Inc.	ACTIVE